BioLife Solutions, Inc.
BLFS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $28,067 | $25,421 | $23,941 | -$3,424 |
| % Growth | 10.4% | 6.2% | 799.2% | – |
| Cost of Goods Sold | $9,288 | $8,988 | $8,155 | $11,695 |
| Gross Profit | $18,779 | $16,433 | $15,786 | $8,271 |
| % Margin | 66.9% | 64.6% | 65.9% | -241.6% |
| R&D Expenses | $2,709 | $2,719 | $2,204 | $1,085 |
| G&A Expenses | $12,074 | $11,396 | $11,501 | $6,588 |
| SG&A Expenses | $14,602 | $14,128 | $14,098 | $5,797 |
| Sales & Mktg Exp. | $2,528 | $2,732 | $2,597 | -$791 |
| Other Operating Expenses | $847 | $16,229 | $702 | -$23,387 |
| Operating Expenses | $18,158 | $33,076 | $17,004 | -$16,505 |
| Operating Income | $621 | -$16,643 | -$1,218 | $1,386 |
| % Margin | 2.2% | -65.5% | -5.1% | -40.5% |
| Other Income/Exp. Net | $82 | $931 | $784 | $157 |
| Pre-Tax Income | $703 | -$15,712 | -$434 | $1,543 |
| Tax Expense | $82 | $126 | $14 | -$131 |
| Net Income | $621 | -$15,838 | -$448 | $12,459 |
| % Margin | 2.2% | -62.3% | -1.9% | -363.9% |
| EPS | 0.01 | -0.33 | -0.01 | 0.27 |
| % Growth | 103% | -3,373.7% | -103.5% | – |
| EPS Diluted | 0.01 | -0.33 | -0.01 | 0.26 |
| Weighted Avg Shares Out | 47,925 | 47,798 | 47,135 | 46,649 |
| Weighted Avg Shares Out Dil | 48,724 | 47,798 | 47,135 | 48,033 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $684 | $681 | $0 |
| Interest Expense | $508 | $0 | $0 | -$116 |
| Depreciation & Amortization | $1,335 | $1,382 | $1,384 | $1,704 |
| EBITDA | $2,546 | -$14,330 | $166 | $6,747 |
| % Margin | 9.1% | -56.4% | 0.7% | -197.1% |